Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06618638
NA

Shared Decision Making for Choosing Autosomal DOminant Polycystic Kidney Disease Treatment

Sponsor: Seoul National University Hospital

View on ClinicalTrials.gov

Summary

The purpose of this study is to generate clinical evidence and assess the feasibility of a shared decision-making (SDM) model for the selection of Tolvaptan in patients with ADPKD.

Official title: Clinical Trial for Shared Decision Making Model for Choosing Pharmacotherapy in ADPKD Patients

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

340

Start Date

2024-10-21

Completion Date

2026-09-30

Last Updated

2024-11-07

Healthy Volunteers

No

Interventions

BEHAVIORAL

Shared decision making model

Shared decision making model for choosing pharmacotherapy in ADPKD patients. This newly developed shared decision making model follows the SHARE approach and includes patient education, identifying values and preferences, reaching a decision and evaluating.

BEHAVIORAL

Usual Care

Usual care for ADPKD patients

Locations (9)

Hallym University Kangnam Sacred Heart Hospital

Anyang-si, Gyeonggi-do, South Korea

Seoul National University Hospital

Seoul, Republic of Korea, South Korea

InjeUniversityBusanPaikHospital

Busan, South Korea

Keimyung University Dongsan Medical Center

Daegu, South Korea

Chonnam National University Hospital

Gwangju, South Korea

Kangbuk Samsung Hospital

Seoul, South Korea

Asan Medical Center

Seoul, South Korea

Seoul National University Boramae Hospital

Seoul, South Korea

Korea University Guro Hospital

Seoul, South Korea